Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...

Doctors believe new test could lead to earlier diagnoses and more effective treatment for thousands of patients ...

Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer. IBD includes ...

eddows – stock.adobe.com While colonoscopies can detect precancerous cells in the bowels, new research by the Institute of Cancer Research in the UK was able to better predict which of these ...

A new method for detecting bowel cancer is more than 90% accurate at predicting which higher risk people will develop the disease, research found. People with inflammatory bowel disease (IBD ...

Director of the centre for evolution and cancer at The Institute of Cancer Research, Professor Trevor Graham, said most people living with those diseases would not develop bowel cancer as a result ...

To identify people's cancer risk, scientists at the Institute of Cancer Research (ICR), working with doctors at St Mark's in London, the UK's specialist bowel hospital, found that people with IBD ...

A new test to identify people with inflammatory bowel disease with the highest risk of bowel cancer is more than 90 percent accurate, research has shown. People with inflammatory bowel disease ...

Professor Kristian Helin, chief executive at the Institute of Cancer Research, London, said, "Drug resistance is one of the biggest problems we face in treating cancer. Finding drugs that can slow ...

Michael S. Gordon, M.D., Chief Medical Officer of HonorHealth Research Institute, today was named a Fellow of the American Society of Clinical Oncology (FASCO), the world’s leading professional ...

Director General of the National Institute for Cancer Research and Treatment, Dr. Usman Malami Aliyu, who was a guest on Channels Television’s breakfast show, … Continue reading FG To Provide Free Can ...

Scientists from The Institute of Cancer Research, London, showed that the drug, NXP800, discovered at the same institute, slowed the growth of prostate cancer cells, including in cancer cells that are ...